MET and cancer: Moreover, while VEGF inhibition has been often connected to tumor VCO, VEGF is also known to downregulate cancer cell invasion via enhanced recruitment of the protein tyrosine phosphatase 1B (PTP1B, which can directly dephosphorylate MET and VEGFR2), thereby suppressing cancer cell migration (85).